TP53 and cancer: The hTC and Brms1 promoters show fairly similar results; both show cancer-specific killing for both p53-Bad and p53-Bad* in all three cancer cell lines compared with normal cells, though the degree of specificity is not as high as in − 279/+ 5 (Figs. 9 and 11).